Dapansutrile preserves pancreatic beta‐cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis

Key Points

• Preserving pancreatic beta-cell function is crucial for effective diabetes management, and dapansutrile plays a significant role.
• The treatment directly targets the NLRP3 inflammasome, which impacts beta-cell performance and health.
• Analysis reveals that mitochondrial homeostasis is maintained by dapansutrile, critical to regulating insulin vesicle fusion.
• These findings highlight potential avenues for diabetes management strategies, emphasizing the need for further research into this treatment.